Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Humedix Co Ltd banner
H

Humedix Co Ltd
KOSDAQ:200670

Watchlist Manager
Humedix Co Ltd
KOSDAQ:200670
Watchlist
Price: 43 250 KRW -5.57% Market Closed
Market Cap: ₩485.7B
Write Note Create Alert Ask AI

Gross Margin

47.3%
Current
Improving
by 1.2%
vs 3-y average of 46.1%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
47.3%
=
Gross Profit
₩76.4B
/
Revenue
₩161.5B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
47.3%
=
Gross Profit
₩76.4B
/
Revenue
₩161.5B

Peer Comparison

Country Company Market Cap Gross
Margin
KR
Humedix Co Ltd
KOSDAQ:200670
448.1B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
959.3B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
291.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
238.2B GBP
Loading...
CH
Novartis AG
SIX:NOVN
242.2B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
305.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
151.4B USD
Loading...
UK
GSK plc
XETRA:GS71
103.6B EUR
Loading...

Market Distribution

Higher than 83% of companies in Korea
Percentile
83rd
Based on 2 511 companies
83rd percentile
47.3%
Low
-646.5% — 12.8%
Typical Range
12.8% — 32.2%
High
32.2% — 54 001.3%
Distribution Statistics
Korea
Min -646.5%
30th Percentile 12.8%
Median 19.7%
70th Percentile 32.2%
Max 54 001.3%

Other Profitability Ratios

Humedix Co Ltd
Glance View

Market Cap
485.7B KRW
Industry
Pharmaceuticals

Humedix Co., Ltd. engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2014-12-26. The firm distributes its products within domestic market and to overseas markets

Intrinsic Value
46 497.48 KRW
Undervaluation 7%
Intrinsic Value
Price
H
What is Intrinsic Value?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
47.3%
=
Gross Profit
₩76.4B
/
Revenue
₩161.5B
What is Humedix Co Ltd's current Gross Margin?

The current Gross Margin for Humedix Co Ltd is 47.3%, which is above its 3-year median of 46.1%.

How has Gross Margin changed over time?

Over the last 3 years, Humedix Co Ltd’s Gross Margin has increased from 43.9% to 47.3%. During this period, it reached a low of 43.5% on Mar 31, 2024 and a high of 47.8% on Mar 31, 2025.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.